Show items per page
Elements: 18
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
No Longitudinal Mitochondrial DNA Sequence Changes in HIV-infected Individuals With and Without Lipoatrophy Ortiz, M.; Poloni, Estella S.; Furrer, H.; Kovari, H.; ... Tarr, P. E. 2011
add to browser selection
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir Lubomirov, Rubin; di Iulio, J.; Fayet, A.; Colombo, Sara; ... Telenti, A. 2010
add to browser selection
Cohort profile: the Swiss HIV Cohort study Schoeni-Affolter, Franziska; Ledergerber, B.; Rickenbach, M.; Rudin, C.; ... Francioli, P. 2010
add to browser selection
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load Alizon, Samuel; von Wyl, V.; Stadler, T.; Kouyos, R. D.; ... Bonhoeffer, S. 2010
add to browser selection
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals Arab-Alameddine, M.; Di Iulio, J.; Buclin, Thierry; Rotger, M.; ... Csajka, C. 2009
add to browser selection
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study Bellini, C.; Keiser, Olivia; Chave, J-P; Evison, Jm; ... Cavassini, M. 2009
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance Yerly Ferrillo, Sabine; Vora, S.; Rizzardi, P.; Chave, J. P.; ... Perrin, Luc 2001
add to browser selection
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study Boubaker, K.; Flepp, Markus; Sudre, Philippe; Furrer, Hansjakob; ... Telenti, A. 2001
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
VIH: épidemiologie et traitement--2000 Telenti, A.; Hirschel, Bernard 2000
add to browser selection
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Greub, Gilbert; Ledergerber, Bruno; Battegay, M.; Grob, P.; ... Telenti, A. 2000
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Opravil, M.; Telenti, A.; ... Weber, R. 1999